Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Takeda writes off its $1B obesity deal with Amylin
Takeda writes off its $1B obesity deal with Amylin
Takeda writes off its $1B obesity deal with Amylin
Submitted by
admin
on December 28, 2012 - 11:59am
Source:
Fierce Biotech
News Tags:
Amylin
Takeda
Headline:
Takeda writes off its $1B obesity deal with Amylin
Do Not Allow Advertisers to Use My Personal information
